Actym Therapeutics (Series A)
Funding Details
- Date Award
- May 20, 2025
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $34,000,000
Company Info
- Founding Year
- 2017
- Founders
- Christopher Thanos Ph.D., Laura Hix Glickman Ph.D., Amit Kumar Ph.D.
- Company Description
- Actym Therapeutics has developed a microbial-based immunotherapy platform called STACT (S. Typhimurium Attenuated Cancer Therapy) that specifically enriches in many types of solid tumors and not in healthy tissue, delivering multiplexed immuno-modulatory payloads directly to tumor-resident immune cells.
- Market
- Immunotherapy
- Location
- Berkeley, California, USA
- Coinvestors
- Boehringer Ingelheim Venture Fund, Illumina Ventures, JLo Ventures, Korea Investment Partners, Panacea Ventures